TIGIT expression is upregulated and DNAM-1 expression in CD8+ TILs is decreased in melanoma and AML patients, indicating the role of a TIGIT/DNAM-1 imbalance in tumor progression. Here, CD226 is linked to acute myeloid leukemia.